Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
NCT ID: NCT01830413
Last Updated: 2013-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
450 participants
OBSERVATIONAL
2013-04-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Ischemic Conditioning Combined With Endovascular Stenting for Symptomatic Intracranial Atherosclerotic Stenosis
NCT05653505
Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China
NCT01968122
Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)
NCT05707442
Clinical Registration Trial of Intracranial Stenting for Patients With Symptomatic Intracranial Artery Stenosis(CRTICAS)
NCT01994161
The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Intracranial Atherosclerotic Stenosis
NCT05593224
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stenting
cerebral artery stenting for systematic Intracranial artery stenosis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* medical failure patient with systematic Intracranial artery stenosis
* More than 3 weeks after most recent ischemic stroke
* Digital Subtraction Angiography(DSA) showed ≥70% stenosis in target intracranial artery
* Imaging test within 1 week showed bad collateral circulation in target vessel area
* Diseased vessel diameter≥2mm, length \<15mm, distal vessel is normal
Exclusion Criteria
* Acute stroke or TIA within 3 weeks
* Pure penetrating branch stenosis showed by cerebral imaging
* Non-atherosclerosis pathology for the stenosis
* Intracranial hemorrhage in target vessel area within 6 weeks; or potential cardiac thrombus source
* Intracranial tumor, arterial aneurysm or intracranial arteriovenous malformation
•\>50% stenosis in extracranial carotid artery or vertebral artery in operation side; Known contradiction to heparin, aspirin, clopidogrel, anesthesia or contrast; hemoglobin \<10g/dl，platelet count \<100000
* Modified Rankin score ≥3 related to target vessel;
* INR(International Normalized Ratio)\>1.5(irreversible），persist hemorrhage risk; life expectancy \< 1year
* Pregnant or beast-feeding
* Not suitable for endovascular stenting judged by Indication Judgement Committee
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tiantan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhongrong Miao
Doc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhongrong Miao, M.D.
Role: STUDY_CHAIR
Tiantan Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Tiantan Hospital
Beiing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
stent-2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.